Family Bank: Cordlife - Singapore

About

Cordlife Group Limited (“Cordlife”, together with its subsidiaries, the “Group”), founded in 2001, owns and operates Asia’s largest network of private cord blood banks. The Group is committed to ensuring the health and well-being of both mother and child, amongst others. Listed on the Mainboard of the Singapore Exchange since 2012, the Group is a pioneer in private cord blood banking in Asia with extensive transplant experience, having processed and stored more than 400,000 cord blood, cord lining, cord tissue, and placenta stem cell samples. Cordlife is an industry leader in Hong Kong, Indonesia, and the Philippines and one of the top three market leaders in India and Malaysia. Through its majority-owned subsidiary in Malaysia, Stemlife Berhad, Cordlife has an indirect stake in Thailand’s largest private cord blood bank, Thai Stemlife. In addition to cord blood, cord lining, cord tissue, and placenta banking, Cordlife offers families a comprehensive suite of clinical diagnostics, including non-invasive prenatal testing, paediatric vision screening, and newborn metabolic screening. Cordlife strives to ensure reliable quality and is committed to a customer-centric approach.

Labs and Locations

Cordlife Group Limited: 1 Yishun Industrial Street 1 #06-01/09, A'Posh Bizhub Singapore 768160

Business Experience

Cordlife inhabits a distinctive niche in the healthcare industry. The Cordlife Group is one of the foremost private cord blood banks to have gained a solid foothold in Asia. The Cordlife Group is composed of:

• Cordlife Group Limited – Singapore
• Cordlife (Hong Kong) Limited - Hong Kong & Macau
• Health Baby Biotech (Hong Kong) Co., Limited – Hong Kong & Macau
• Cordlife Sciences India Pvt Limited - India & Bangladesh
• PT Cordlife Persada - Indonesia
• Cordlife Medical Philippines, Inc. – the Philippines
• StemLife Berhad – Malaysia & Brunei
• THAI StemLife - Thailand, Myanmar, Laos, Cambodia

Collection Kit

The kit contains a sterile, double wrapped blood bag pre-loaded with the anti-coagulant CPDA-1, along with disinfectant Povidone Iodine swabstick.

Transportation container

The collection kit is constructed with thermal insulation and validated to maintain room temperature for up to 48 hours during transportation back to the laboratory.

Shipping Info

Cordlife provides dedicated staff to pick up the cord blood sample from Singapore hospitals upon notification.

Processing Method

Stem cells are separated from the cord blood using the semi-automated and closed AXP system. The final component is the buffy coat layer of the blood, which holds both white cells and stem cells.

Components Stored

Parents are provided with a report describing test results for the buffy coat holding white cells and stem cells including total nucleated cells (TNC), post processing sterility, viable CD34+ counts, as well as maternal blood infectious disease results.

Storage Method

Final cord blood storage is in 25 ml cryo bag encased in an overwrap. Samples are kept in a quarantine freezer, then moved to long term freezer after they pass testing. Stem cells are stored in the vapour phase of cryogenic nitrogen. 

In 2024, Cordlife installed a new laboratory monitoring system which tracks the temperature of their 27 cryogenic storage tanks and other critical equipment. This system ensures 24/7 real-time surveillance both on site and remotely. There are two staff on call for the laboratory at all times. If a temperature anomaly occurs they will both be notified by text, email, and phone call. The laboratory directors will be alerted 10 minutes later. After another 10-minute interval, the system will alert top management such as the group CEO. The monitoring system is also equipped with its own uninterruptible" power supply.

Licensing & Accreditation

• Certified by Singapore Ministry of Health

Clinical Experience

The Group has made 77 cord blood releases to 21 healthcare institutions in ten different countries, allowing its clients to use their cord blood for transplantation or cellular therapy. Cordlife has also assisted its clients in the release of 21 cord lining, cord tissue, and cord tissue mesenchymal stem cell releases for medical use. All of the samples processed and stored by Cordlife were used successfully in cellular therapy, which is the ultimate validation of the Group’s processing and storage capabilities..

Insurance

Cordlife clients will be covered by a program known as the Cordlife Care360 – a holistic program aimed to safeguard our client and their family.

1) Cordlife provides the coverage of possible pregnancy and childbirth complications*.
2) Cordlife will cover future storage payments if death or total permanent disability* occurs to either biological parent of Child during the contractual storage period.
3) Cordlife assures clients a cord blood unit of suitable match or US$25,000 to defray medical costs if the cord blood loses its viability at point of transplant*.
4) Cordlife will cover the cost for additional tests required in the event of a transplant* - matching (HLA resolution test) and viability (CFU assay).
5) Cordlife has taken additional insurance coverage, to safeguard client and their family from financial loss resulting from direct malpractice*.

* Terms and Conditions apply

Prices

For more information, please submit a price plan enquiry

Additional Services

Cordlife has an exclusive license on patented technology to harvest and store two types of stem cells from the lining of the umbilical cord. This cord lining contains both Epithelial Stem Cells (EpSCs) and Mesenchymal Stromal Cells (MSCs).